49 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... and Treating Penicillium ... Infections in HIV-AIDS Preventing ... Penicilliosis #IDSA
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... Enteric #Bacterial #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... and Treating Chagas ... Chagas disease Treating ... Trypanosomiasis #IDSA
Management of Apnea in Procedural Sedation
 • Apnea Definition: The cessation of breathing for more than
The cessation of breathing ... OR cessation of breathing ... Risk Factors, Diagnosis ... , Prevention, Management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... or been newly diagnosed ... following initial diagnosis ... HumanPapillomavirus #IDSA
DKA Resuscitation Checklist
 - Diagnostic evaluation 
 - Crystalloid 
 - Electrolyte repletion 
 - High-flow
Resuscitation Checklist - Diagnostic ... patient has elevated work ... of breathing or
Post-Intensive Care Syndrome (PICS)
Symptoms of PICS:
 - Physical Domain: Generalized weakness, Fatigue, Difficulty walking
 - Cognitive
Hyperglycemia PREVENTION ... awakening and breathing ... screening and prevention ... Syndrome #PICS #diagnosis
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... for Treating Visceral ... Leishmaniasis in HIV-AIDS Treating ... every 21 days Treating ... Leishmaniasis #Prevention
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for Treating Mucosal ... candida #mucosal #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... and Treating Toxoplasma ... #Encephalitis #IDSA ... #Prevention #Treatment